Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress

Stock Information for Timber Pharmaceuticals Inc Com (New)

Loading

Please wait while we load your information from QuoteMedia.